David N Hackney MD
General Gynecology, Maternal & Fetal Medicine/High Risk
Division Director and Associate Prof. University Hospitals Cleveland Medical Center / CWRU
Join to View Full Profile
11100 Euclid AveCleveland, OH 44106
Phone+1 216-844-3941
Dr. Hackney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UPMC Medical EducationFellowship, Maternal-Fetal Medicine, 2005 - 2008
Ohio State University/Mt Carmel HospitalResidency, Obstetrics and Gynecology, 2000 - 2004
University of Pittsburgh School of MedicineClass of 2000
Certifications & Licensure
OH State Medical License 2000 - 2026
NY State Medical License 2008 - 2013
PA State Medical License 2005 - 2008
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Maternal-Fetal Medicine
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age Start of enrollment: 2023 Jan 13
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Sonographic surveillance and perinatal outcomes among pregnancies with periviable fetal growth restriction.Felicia V LeMoine, Angela C Ranzini, Marisa R Imbroane, Esha V Ghosalkar, David N Hackney
Journal of Perinatal Medicine. 2025-08-22 - 3 citationsProgesterone inactivation in decidual stromal cells: A mechanism for inflammation-induced parturition.Angela DeTomaso, Hyeyon Kim, Jacqueline Shauh, Anika Adulla, Sarah Zigo
Proceedings of the National Academy of Sciences of the United States of America. 2024-06-18 - 3 citationsResearching COVID to enhance recovery (RECOVER) pregnancy study: Rationale, objectives and design.Torri D Metz, Rebecca G Clifton, Richard Gallagher, Rachel S Gross, Leora I Horwitz
Medrxiv. 2023-04-24
Press Mentions
These Two Stimulants Should Be Contraindicated During Pregnancy, Group SaysMay 29th, 2025- Trial Shines Light on Questionable Benefits of Tocolytics for Preterm BirthJanuary 31st, 2025
- Air Pollution Tied to Preterm Birth RiskNovember 13th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
